title: Re: Use of Phosphodiesterase Type 5 Inhibitors May Adversely Impact Biochemical Recurrence after Radical Prostatectomy: U. Michl, F. Molfenter, M. Graefen, P. Tennstedt, S. Ahyai, B. Beyer, L. Budäus, A. Haese, H. Heinzer, S. J. Oh, G. Salomon, T. Schlomm, T. Steuber, I. Thederan, H. Huland and D. Tilki J Urol 2015;193:479-483.
authors.affiliation: Postgraduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India.
authors.forename: Girdhar S
authors.initials: GS
authors.lastname: Bora
authors.affiliation: Postgraduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India.
authors.forename: Vijayant Govinda
authors.initials: VG
authors.lastname: Gupta
authors.affiliation: Postgraduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India.
authors.forename: Ravimohan S
authors.initials: RS
authors.lastname: Mavuduru
mesh_terms: D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000139:chemically induced*; D058986:Phosphodiesterase 5 Inhibitors / Q000009:adverse effects*; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000139:chemically induced* / Q000601:surgery*
chemical_list: D058986:Phosphodiesterase 5 Inhibitors